Atlas Trials

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Clinical trial NCT00352079 · TERMINATED

Trial details

NCT number
NCT00352079
Sponsor
NCIC Clinical Trials Group
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2007-01-04
Primary completion
2012-01-06
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.